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Koza et al state that MPV can be affected by several factors such as nonalcholic fatty liver disease, medication, and diet therapies. We excluded patients with known hepatic diseases in our study. As we mentioned in our study limitation section, we could not evaluate the medical history of patients that can affect platelet function.
Koza et al 2 remark that the MPV reference value was not defined in our study. To our knowledge, there are no accepted cutoff values for MPV in the literature. If they mean a reference range of MPV, it is 6.0 to 9.5 fL. Also, they noted that MPV values of samples collected in EDTA are at least 9% higher than those from citrated samples. All MPV values were measured in dipotassium EDTA tubes. There was no different approach in MPV measurements between our patients and groups. Therefore, we do not believe that this factor significantly influenced our results.
Koza et al 2 wonder why we excluded treatment with aspirin. There are controversial findings about the effect of aspirin on MPV. Erhart et al reported in an in vitro and randomized double-blind, placebo-controlled study that repeated blood sampling during a 7-day treatment with 250 mg aspirin daily showed an increased platelet count. 3 Because of the conflicting results about the effect of aspirin on MPV, we excluded the patients who received aspirin. Additionally, we collected the blood samples at admission only.
Finally, we evaluated the MPV-platelet ratio during statistical analysis, but there was no difference in our patient groups.
